dr now glp-1 FDA Approves First Pill For years, you've asked me

13 (6), e1285 (2023)

Sold as Mounjaro (for diabetes) and Zepbound (for weight management), tirzepatide has quickly become the most prescribed alternative for people who want more weight loss than semaglutide delivers

These distinctions reflect different developmental pathways and pharmacological optimisations

Over-loss and muscle pooled SURMOUNT, BMI below 22 reached by about 7% (as early as week 12), toward about 15% by week 88 in the longest trial, clinical underweight under 0.4% (Almandoz 2026)

The expiry date represents the point beyond which the manufacturer can no longer guarantee the medication's quality, safety, and efficacy

Therapeutic challenges of post-traumatic stress disorder: focus on the dopaminergic system